Structure and properties of modified interferons
US4769233A · kind A · utility
17Cited by
2References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 3, 1985 |
| Grant date | Sep 6, 1988 |
| Priority date | — |
| Expiry date | May 3, 2005 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/142
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A composition of matter comprising a polypeptide of the formula: EQU A-R.sub.1 -B-R.sub.2-22.sup.-C wherein: PA1 A is the amino acid sequence 1-16 of human beta interferon; PA1 R.sub.1 is cysteine, serine or alanine; PA1 B is the amino acid sequence 18-31 of human beta interferon; PA1 R.sub.2-22 are naturally occurring amino acids; PA1 C is the amino acid sequence 53-166 of human beta interferon.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.